Literature DB >> 2347930

Factors that predict scores on the Dissociative Experiences Scale.

G R Norton1, C A Ross, M F Novotny.   

Abstract

Bernstein and Putnam (1986) recently developed the Dissociative Experiences Scale (DES), a reliable and valid measure of dissociative experiences. The purpose of this study was to determine the relationship of the DES to other measures of psychopathology and cognitive functioning. Seventy-six female and 43 male university students were administered the DES, the Hopkins Symptom Checklist (HSCL-90), the Maudsley Obsessional-Compulsive Inventory (MOCI), the Tellegen Absorption Scale (TAS), and the Barnes-Vulcano Rationality Test (BVRT). A standard multiple regression was computed that used the DES as the criterion variable and the HSCL-90, MOCI, TAS, and BVRT as predictor variables. The results showed that 61% of the variance for DES scores could be predicted by three subscales of the HSCL-90 (Phobic Anxiety, Anger-Hostility, Somatization) and the TAS and BVRT. The importance of the relationship between the predictor variables and the DES for understanding dissociative disorders, especially multiple personality disorder, was discussed.

Entities:  

Mesh:

Year:  1990        PMID: 2347930     DOI: 10.1002/1097-4679(199005)46:3<273::aid-jclp2270460304>3.0.co;2-x

Source DB:  PubMed          Journal:  J Clin Psychol        ISSN: 0021-9762


  2 in total

1.  Magic and memory: using conjuring to explore the effects of suggestion, social influence, and paranormal belief on eyewitness testimony for an ostensibly paranormal event.

Authors:  Krissy Wilson; Christopher C French
Journal:  Front Psychol       Date:  2014-11-13

2.  Comparative effectiveness of biofeedback and injectable bulking agents for treatment of fecal incontinence: Design and methods.

Authors:  Adil E Bharucha; Marie G Gantz; Satish S Rao; Ann C Lowry; Heidi Chua; Tennekoon Karunaratne; Jennifer Wu; Frank A Hamilton; William E Whitehead
Journal:  Contemp Clin Trials       Date:  2021-06-15       Impact factor: 2.261

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.